1-7 of 7
Qing Chen, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Investigation Of p210 Bcr-Abl Rhogef Activity In The Progression Of Chronic Myelogenous Leukemia

Bryan T Ciccarelli, MA, Ilona Tala, PhD, Tinghui Hu, PhD, Dan Li, BS, Ru Chen, PhD, Qing Chen, PhD, Ian P Whitehead, PhD
Journal: Blood
Blood (2013) 122 (21): 3802.
https://doi.org/10.1182/blood.V122.21.3802.3802
Published: 2013
Journal Articles

A p210 BCR/ABL Mutant That Lacks Guanine Nucleotide Exchange Factor Activity Induces Erythroleukemia in a Murine Bone Marrow Transplantation Model,

Ilona Tala, Ru Chen, PhD, Qing Chen, PhD, Ian Whitehead, PhD
Journal: Blood
Blood (2011) 118 (21): 3756.
https://doi.org/10.1182/blood.V118.21.3756.3756
Published: 2011
Journal Articles

Ciprofloxacin Inhibits Bortezomib-Mediated Apoptosis in Multiple Myeloma Models in Association with Induction of Heme Oxygenase-1.

Qing Chen, PhD, Dixie-Lee Esseltine, MD, Rachel B. Neuwirth, PhD, Paul G. Richardson, MD, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2365.
https://doi.org/10.1182/blood.V110.11.2365.2365
Published: 2007
Journal Articles

Targeting the p27 Kip1 E3 Ubiquitin Ligase for the Treatment of Multiple Myeloma and Other Hematological Malignancies.

Qing Chen, PhD, Weilin Xie, PhD, Deborah J. Kuhn, PhD, Peter M. Voorhees, MD, Derek Mendy, MD, Antonia Lopez-Girona, PhD, Veronique Plantevin, PhD, Weiming Xu, PhD, Laura De Parseval, PhD, Laura G. Corral, PhD, Emilia Glezer, PhD, Kyle Chan, PhD, Frank Mercurio, PhD, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 372.
https://doi.org/10.1182/blood.V108.11.372.372
Published: 2006
Journal Articles

Development of Immunoproteasome-Specific Inhibitors as Novel Anti-Cancer Drugs.

Deborah J. Kuhn, PhD, Peter M. Voorhees, MD, Qing Chen, PhD, John S. Strader, Frank Bruzzese, PhD, Jeffrey P. Ciavarri, PhD, Zhigen Hu, PhD, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3458.
https://doi.org/10.1182/blood.V108.11.3458.3458
Published: 2006
Journal Articles

The Novel, Irreversible Proteasome Inhibitor PR-171 Demonstrates Potent Anti-Tumor Activity in Pre-Clinical Models of Multiple Myeloma, and Overcomes Bortezomib Resistance.

Deborah J. Kuhn, PhD, Qing Chen, PhD, Peter M. Voorhees, MD, John S. Strader, Kevin D. Shenk, PhD, Congcong M. Sun, PhD, Susan D. Demo, PhD, Mark K. Bennett, PhD, Fred W. van Leeuwen, PhD, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3461.
https://doi.org/10.1182/blood.V108.11.3461.3461
Published: 2006
Journal Articles

Inhibition of Kinesin Spindle Protein Induces Apoptosis and Overcomes Drug Resistance in Models of Multiple Myeloma.

Qing Chen, PhD, Vishwan Pamarthi, Deborah J. Kuhn, PhD, Peter M. Voorhees, MD, John S. Strader, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3425.
https://doi.org/10.1182/blood.V108.11.3425.3425
Published: 2006